ClinicalTrials.Veeva

Menu

Future Optimal Research and Care Evaluation - Aortic Stenosis (FORCE-AoS)

S

St. Antonius Hospital

Status

Enrolling

Conditions

Severe Aortic Valve Stenosis
Moderate Aortic Valve Stenosis

Treatments

Behavioral: Quality of life questionnaires will be assessed in addition to standard care

Study type

Observational

Funder types

Other

Identifiers

NCT06168123
Z23.069

Details and patient eligibility

About

In the past decade the treatment of aortic valve stenosis has rapidly changed. At first, transcatheter aortic valve implantation (TAVI) was a last resort option for inoperable patients. Nowadays, it more and more becomes an alternative to surgical aortic valve replacement (SAVR) - also in younger and lower risk patients. This poses important questions to clinical practise regarding the optimal life-time management of each individual patient. Which involves (durability of) treatment modality (surgical vs. transcatheter vs. conservative treatment) as well as the duration and type of the required antithrombotic treatment.

Objective: to evaluate the effect of treatment modality (surgical vs. transcatheter vs. conservative treatment) and its complications on quality of life and survival in AoS patients.

Enrollment

800 estimated patients

Sex

All

Ages

18 to 110 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Older than 18 years of age
  • Severe or moderate aortic stenosis

No exclusion criteria are applicable to this registry

Trial contacts and locations

1

Loading...

Central trial contact

Christiaan Overduin

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems